Clinical Trials · NCT06691243

Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV

Name: Evaluation Of Semaglutide in Adults With Cocaine Use Disorder With and Without HIV
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

RecruitingPhase 2Semaglutide

Phase: Phase 2
Recruitment status: Recruiting
Sponsor: University of Maryland, Baltimore
Enrollment: 40
Start date: Aug 2025
Locations: 2 sites, United States
Primary endpoint: Safety of semaglutide in patients with cocaine use disorder (CUD) with and without HIV

View Semaglutide compound reference